Lobbying Information
Subject Matters
- Agriculture
- Health
- Infrastructure
- Research and Development
- Science and Technology
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- National Research Council of Canada - Digital Technology Adoption Pilot Program contribution for an enterprise resource planning (ERP) and customer relations management (CRM) system which integrates our finance, accounting, manufacturing, project and other supply chain management business as well as sales and marketing management, and customer service operations processes.
- National Research Council of Canada Industrial Research Assistance Program contribution for research and development of a second generation E. coli O157 Cattle vaccine
- Urocidin plant expansion project relating to the future expansion of the manufacturing capacity of the current Pointe-Claire facilities.
Policies or Program
- Potential research program utilizing one of the Company's products in human clinical studies related to post-traumatic stress disorder.
- Support creation of National E. coli vaccination program for Canadian cattle sponsored by the government.
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Business Development Bank of Canada (BDC)
-
Canada Economic Development for Quebec Regions
-
Canadian Food Inspection Agency (CFIA)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
Office of the Information and Privacy Commissioner (OIPC)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Revenue Canada (RC)
-
Senate of Canada
-
Veterans Affairs Canada (VAC)
In-house Corporation Details
Description of activities
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide.
Responsible officer name and position during the period of this registration
Graeme McRae,
President & CEO
Government funding
End date of the last completed financial year:
2013-06-30
List of Government Funding
Government Institution
|
Funding Received in Last Financial Year
|
Funding Expected in Current Financial Year
|
National Research Council (NRC)
|
$118,901.00
|
Yes
|
In-house Corporation Contact Information
Address:
231 Dundas Street East
P.O. Box 1570
Belleville, ON K8N 5J2
Canada
Telephone number:
613-966-8058
Ext.
1254
Fax number:
613-966-6997
Parent Company Information
Bioniche Life Sciences Inc. is not a subsidiary of any other parent companies.
Subsidiary Beneficiary Information
Bioniche Life Sciences Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Charles (Rick) Culbert,
President, Bioniche One Health |
No public offices held
- Mohamed Elrafih,
Vice President Manufacturing Operations |
No public offices held
- Brian Ford,
Chief Financial Officer |
No public offices held
- Susan Goebel,
E. coli Project Manager |
No public offices held
- Graeme McRae,
President and CEO (Director) |
No public offices held
- Mairi Phillips,
Vice-President, Legal Services |
No public offices held
- Michael Rubin,
Vice President, Business Development |
No public offices held
- Jennifer Shea,
Vice President Communications, Investor and Government Relations and Assistant Secretary |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
No lobbyists added